Ybrain

About:

Ybrain develops medical devices that measure & cure neuropsychiatric illness based on neuroscience.

Top Investors: DSC Investment, Company K Partners, KT&G Corporation, STIC Ventures, InterVest

Description:

We have built wearable devices based on tDCS that cure Major Depressive Disorder(MDD) and other psychiatric illnesses and currently carrying out clinical trials in Korea. We are also building big data platform with brain signals detected and collected from Ybrain’s own qEEG software for more targeted and personalized treatments and services.

Total Funding Amount:

$13.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seongnam, Kyonggi-do, South Korea

Founded Date:

2013-02-01

Contact Email:

inquiries(AT)ybrain.com

Founders:

Kiwon Lee

Number of Employees:

11-50

Last Funding Date:

2022-02-23

IPO Status:

Private

Industries: